US$ 23.78
cvs caremark semaglutide 💊 BIG NEWS FOR WEIGHT LOSS ACCESS For millions of Americans covered through plans, this could mean more options—and potentially lower out-of-pocket costs—for obesity treatment. Why does this matter for Healthy Returns: Novo Nordisk CVS
Description
Wegovy, which is a weekly injection, is now approved for adults with MASH and moderate-to-advanced levels of fibrosis, or excessive scar tissue in the liver

Lactation : There are no data on the presence of Semaglutide in human milk, the effects on the breastfed infant, or the effects on milk production

But theres a catch

Treatment should be discontinued if less than 5% of body weight is lost after 3 months

Disadvantages of semaglutide include the fact that they are weekly injection (except the oral form, Rybelsus), higher costs, and side effects

The Claude Bernard Lecture, 2005
